Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60dee06ed4f22120f641ed3b23ca355a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e7214bb2f0b606760ec275472a96e6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b24ef938837748cbc25e3ab781ded3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-80 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-80 |
filingDate |
2005-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ec51ae8c4c53beb9c1a9d4edd3be36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d19d31758c6f741faeb7646b54e80d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e386a08a8190397d04ff455a0073b052 |
publicationDate |
2006-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006183922-A1 |
titleOfInvention |
CB2-selective cannabinoid derivatives |
abstract |
Cannabinoid derivatives that exhibit specificity for the CB 2 cannabinoid receptor are provided. The analogues are tetrahydrocannabinols and hydroxyhexahydrocannabinols, and are useful for the treatment of pain, inflammation, and cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021091908-A1 |
priorityDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |